 | Up a level |
Rovó, Alicia; Gras, Luuk; Piepenbroek, Brian; Kröger, Nicolaus; Reinhardt, Christian H.; Radujkovic, Aleksandar; Blaise, Didier; Kobbe, Guido; Niityvuopio, Riitta; Platzbecker, Uwe; Sockel, Katja; Hunault-Berger, Mathilde; Cornelissen, J J; Forcade, Edouard; Bourhis, Jean Henri; Chalandon, Yves; Kinsella, Francesca; Nguyen-Quoc, Stéphanie; Maertens, Johan; Elmaagacli, Ahmet; ... (2024). Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT. American journal of hematology, 99(2), pp. 203-215. Wiley-Liss 10.1002/ajh.27150
Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Müller, Tony A; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L; Melchinger, Wolfgang; Duquesne, Sandra; Schmitt-Graeff, Annette; Osswald, Lena; Yan, Kai-Li; Weber, Arnim; Tugues, Sonia; Spath, Sabine; Pfeifer, Dietmar; ... (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine, 24(3), pp. 282-291. Nature Publishing Group 10.1038/nm.4484
